With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.33454-82-9,Lithium trifluoromethanesulfonate,as a common compound, the synthetic route is as follows.
General procedure: N-alkylated product of di/trimeric imidazolium bromide (1.0 equi.)is treated with NaBF4/KPF6/LiCF3SO3 (3.05 equi.) in the presence of10 mL of deionized water at room temperature with stirring for about1 h afforded the anion exchanged product of di/trimeric imidazoliumcation with different anions. After the anion exchanged reaction,Soxhlet extractions is done to removemetallic bromide fromdi/trimericimidazolium salts using 100 mL of dry THF for about 1 h reflux to giverespective imidazolium salt in quantitative yield, 33454-82-9
The synthetic route of 33454-82-9 has been constantly updated, and we look forward to future research findings.
Reference£º
Article; Ganapathi, Pandurangan; Ganesan, Kilivelu; Journal of Molecular Liquids; vol. 233; (2017); p. 452 – 464;,
Metal catalyst and ligand design
Ligand Template Strategies for Catalyst Encapsulation – NCBI